Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis

BACKGROUND: MLKL is the most important executor of necroptosis pathway. Recent studies have demonstrated that MLKL could serve as a potential prognostic biomarker for cancer patients. However, most studies reported so far are limited in discrete outcome and sample size. METHODS: We systematically se...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Binwu, Shi, Deyao, Lv, Xiao, Chen, Songfeng, Huang, Qin, Xie, Mao, Shao, Zengwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044038/
https://www.ncbi.nlm.nih.gov/pubmed/30005626
http://dx.doi.org/10.1186/s12885-018-4655-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044038/
https://www.ncbi.nlm.nih.gov/pubmed/30005626
http://dx.doi.org/10.1186/s12885-018-4655-4

Ejemplares similares